Douglas Kerr Insider Profile
4 Followers
Douglas Kerr, Head of R&D and CMO at Dyne Therapeutics, holds 170.56K shares in Dyne Therapeutics (Ticker: DYN), holds 385.63K shares in Generation Bio (Ticker: GBIO).
Douglas Kerr has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Head of R&D and CMO
Roles that Douglas Kerr holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Douglas Kerr
Douglas Kerr's Trading History
Dyne Therapeutics
Oct 22, 2026
Head of R&D and CMO
Uninformative Buy
―
$2.85M
Generation Bio
Jan 31, 2024
―
Uninformative Buy
6.74K
$2.06M
List of latest transactions for each holding click on a transaction to see Douglas Kerr's performance on stock
You May Also Like
Douglas Kerr insider profile FAQ
What is the percentage of profitable transactions made by Douglas Kerr?
The percentage of profitable transactions made by Douglas Kerr is ―.
What is the average return per transaction made by Douglas Kerr?
The average return per transaction made by Douglas Kerr is ―.
What stocks does Douglas Kerr hold?
Douglas Kerr holds: DYN, GBIO stocks.
What was Douglas Kerr’s latest transaction?
Douglas Kerr latest transaction was an Uninformative Buy of ―.
What was Douglas Kerr's most profitable transaction?
Douglas Kerr’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Douglas Kerr's role in Dyne Therapeutics?
Douglas Kerr's role in Dyne Therapeutics is Head of R&D and CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.